BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8347186)

  • 21. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
    Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
    Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.
    Arlt MJ; Novak-Hofer I; Gast D; Gschwend V; Moldenhauer G; Grünberg J; Honer M; Schubiger PA; Altevogt P; Krüger A
    Cancer Res; 2006 Jan; 66(2):936-43. PubMed ID: 16424028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16F10 melanoma in mice.
    Dabrowska A; Giermasz A; Marczak M; Gołab J; Jakóbisiak M
    Anticancer Res; 2000; 20(1A):391-4. PubMed ID: 10769685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.
    Price A; Shi Q; Morris D; Wilcox ME; Brasher PM; Rewcastle NB; Shalinsky D; Zou H; Appelt K; Johnston RN; Yong VW; Edwards D; Forsyth P
    Clin Cancer Res; 1999 Apr; 5(4):845-54. PubMed ID: 10213221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
    Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
    Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA; Bafetti LM; Stack MS
    Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice.
    Ward BG; Wallace K; Shepherd JH; Balkwill FR
    Cancer Res; 1987 May; 47(10):2662-7. PubMed ID: 3567897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma.
    Prontera C; Mariani B; Rossi C; Poggi A; Rotilio D
    Int J Cancer; 1999 May; 81(5):761-6. PubMed ID: 10328230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cis-hydroxyproline stimulates the growth of rat mammary carcinoma cells.
    Buck TB; Hall AL; Sinha CC; Bunce OR; Thorgeirsson UP
    In Vivo; 2000; 14(1):7-11. PubMed ID: 10757055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a human ovarian carcinoma cell line: UCI 101.
    Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
    Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
    Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
    J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
    Macaulay VM; O'Byrne KJ; Saunders MP; Braybrooke JP; Long L; Gleeson F; Mason CS; Harris AL; Brown P; Talbot DC
    Clin Cancer Res; 1999 Mar; 5(3):513-20. PubMed ID: 10100701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.